This article is part of the supplement: The evolution of anti-TNF therapy in rheumatic disease: experience, insights and advances

Introduction

Anti-TNF therapy: what have we learned in 12 years?

Joachim R Kalden

Arthritis Research & Therapy 2011, 13(Suppl 1):S1 doi:10.1186/1478-6354-13-S1-S1

Accesses  

  • Last 30 days: 47 accesses
  • Last 365 days: 566 accesses
  • All time: 1658 accesses

Cited by

Google Scholar: View citations

ISI Web of Science: View citations

PubMed Central: View citations